GlassScriptPhysician profile
Cary Dean Adkisson
NPI 1659843530
$3,759.46
in general payments reported to CMS, 2019-2025
31 companies · $3,306 in 2025
The $3,306 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $357 · 2022: $80.68 · 2024: $16.15 · 2025: $3,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,001 · Travel and Lodging: $1,253 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,000.70 |
| Travel and Lodging | $1,253.19 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,415.19 | 2025 | |
| Sumitomo Pharma America, INC. | $295.94 | 2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $222.96 | 2025 | Erleada, Akeega |
| Accord Healthcare, INC. | $211.75 | 2025 | |
| Ferring Pharmaceuticals INC. | $168.63 | 2025 | Adstiladrin |
| Novo Nordisk INC | $144.90 | 2021-2022 | |
| Medtronic, INC. | $134.04 | 2022-2025 | Interstim |
| Dendreon Pharmaceuticals LLC | $111.58 | 2025 | Provenge |
| Merck Sharp & Dohme LLC | $97.94 | 2025 | Lynparza, Keytruda |
| Convatec INC. | $82.65 | 2025 | |
| Pfizer INC. | $74.58 | 2025 | |
| Novartis Pharmaceuticals Corporation | $67.59 | 2025 | |
| Agiliti Health, INC. | $66.87 | 2025 | Sonablate Hifu, Coloplast Tfl Drive Laser, Olympus Soltive Tfl Laser |
| Urogen Pharma, INC. | $66.19 | 2025 | |
| Tolmar, INC. | $60.69 | 2025 | Eligard, Jatenzo |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $56.45 | 2021 | |
| Immunitybio, INC. | $55.96 | 2025 | |
| Ethicon US, LLC | $55.75 | 2021 | |
| Endo USA, INC. | $49.18 | 2025 | Xiaflex |
| W. L. Gore & Associates, INC. | $45.30 | 2021 | |
| Currax Pharmaceuticals LLC | $42.04 | 2021-2022 | |
| Antares Pharma, INC. | $37.17 | 2025 | Xyosted |
| Olympus America INC. | $35.22 | 2025 | Itind System |
| Endo Pharmaceuticals INC. | $30.99 | 2021-2022 | |
| Stryker Corporation | $26.70 | 2021 | |
| Boston Scientific Corporation | $20.00 | 2025 | Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $18.59 | 2025 | |
| Procept Biorobotics Corporation | $18.43 | 2025 | |
| Abbott Laboratories | $16.15 | 2024 | Freestyle Libre 3 |
| Teleflex LLC | $15.24 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $14.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cary Adkisson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.